Limits...
Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy

View Article: PubMed Central - PubMed

ABSTRACT

Radiation therapy (RT) alone has been considered for a long time as the standard therapeutic option for limited stage FL, due to its high efficacy in terms of local disease control with a quite significant proportion of “cured” patients (without further relapses at 10–15 years). Multiple therapeutic choices are currently accepted for the management of early stage FL at diagnosis, and better staging procedures as well as better systemic therapy partially modified the role of RT in this setting. RT has also changed in terms of prescribed dose as well as treatment volumes. In this review, we present and discuss the current role of RT for limited stage FL in light of the historical data and the modern RT concepts along with the possible combination with systemic therapy.

No MeSH data available.


Example of involved site radiotherapy in a case of a 43 years old male patient affected with limited stage FL (right inguinal and crural nodes).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5016012&req=5

f1-mjhid-8-1-e2016041: Example of involved site radiotherapy in a case of a 43 years old male patient affected with limited stage FL (right inguinal and crural nodes).


Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy
Example of involved site radiotherapy in a case of a 43 years old male patient affected with limited stage FL (right inguinal and crural nodes).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5016012&req=5

f1-mjhid-8-1-e2016041: Example of involved site radiotherapy in a case of a 43 years old male patient affected with limited stage FL (right inguinal and crural nodes).

View Article: PubMed Central - PubMed

ABSTRACT

Radiation therapy (RT) alone has been considered for a long time as the standard therapeutic option for limited stage FL, due to its high efficacy in terms of local disease control with a quite significant proportion of “cured” patients (without further relapses at 10–15 years). Multiple therapeutic choices are currently accepted for the management of early stage FL at diagnosis, and better staging procedures as well as better systemic therapy partially modified the role of RT in this setting. RT has also changed in terms of prescribed dose as well as treatment volumes. In this review, we present and discuss the current role of RT for limited stage FL in light of the historical data and the modern RT concepts along with the possible combination with systemic therapy.

No MeSH data available.